4
Changes in Ownership
Keros Therapeutics, Inc. Filed Acc 0001732369-26-000008
Options or other derivatives
- CHIEF EXECUTIVE OFFICER acquired 317,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Seehra Jasbir CHIEF EXECUTIVE OFFICER | 2026-02-24 | Grant or award · Employee Stock Option (Right to Buy) | +217,000 | 217,000 | D: show line 1 in the form | |||||
| Seehra Jasbir CHIEF EXECUTIVE OFFICER | 2026-02-24 | Grant or award · Employee Stock Option (right to buy) | +100,000 | 100,000 | D: show line 2 in the form |
Loading xslF345X05/form4-02262026_040216.xml…